The presence of inhibitory RNA elements in the late 3′-untranslated region is a conserved property of human papillomaviruses

Virus Research

Volumn 125, Issue 2, 2007, Pages 135-144

  Zhao, Xiaomin ^a   Rush, Margaret ^a   Carlsson, Anette ^a   Schwartz, Stefan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

HPV; Polyadenylation; RNA; Splicing; UTR

Indexed keywords

DNA; RNA;

3' UNTRANSLATED REGION; ARTICLE; DNA PROBE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 1; HUMAN PAPILLOMAVIRUS TYPE 16; ISOTOPE LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PERSISTENT VIRUS INFECTION; PLASMID; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN MOTIF; RNA PROBE; RNA SPLICING; UTERINE CERVIX CANCER; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TYPING; WART VIRUS;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; HELA CELLS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MOLECULAR SEQUENCE DATA; MUPAPILLOMAVIRUS; RNA, VIRAL;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; HUMAN POLIOVIRUS 1; PAPILLOMAVIRIDAE;

EID: 34247109992     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2006.12.012     Document Type: Article

References (32)

1. Baker C.C. Posttranscriptional regulation of papillomavirus gene expression. In: Billakanti S.R., Calef C.E., Farmer A.D., Halpern A.L., and Myers G.L. (Eds). Human Papillomaviruses: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Theoretical Biology and Biophysics (1997), Los Alamos National Laboratory, Los Alamos
2. Barreau C., Paillard L., and Osborne H.B. AU-rich elements and associated factors: are there unifying principles?. Nucl. Acids Res. 33 (2005) 7138-7150
3. Carlsson A., and Schwartz S. Inhibitory activity of the human papillomavirus type 1 AU-rich element correlates inversely with the levels of the elav-like HuR protein in the cell cytoplasm. Arch. Virol. 145 3 (2000) 491-503
4. Collier B., Goobar-Larsson L., Sokolowski M., and Schwartz S. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J. Biol. Chem. 273 35 (1998) 22648-22656
5. Collier B., Öberg D., Zhao X., and Schwartz S. Specific inactivation of inhibitory sequences in the 5′ end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells. J. Virol. 76 (2002) 2739-2752
6. Cumming S.A., McPhillips M.G., Veerapraditsin T., Milligan S.G., and Graham S.V. Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5′ splice sites that bind a U1 snRNP-like complex. J. Virol. 77 (2003) 5167-5177
7. Cumming S.A., Repellin C.E., McPhilips M., Redford J.C., Clements J.B., and Graham S.V. The human papillomavirus type 3′ untranslated region contains a complex bipartite negative regulatory element. J. Virol. 76 (2002) 5993-6003
8. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., and zur Hausen H. Classification of papillomaviruses. Virology 324 (2004) 17-27
9. Dietrich-Goetz W., Kennedy I.M., Levins B., Stanley M.A., and Clements J.B. A cellular 65-kDa protein recognizes the negative regulatory element of human papillomavirus late mRNA. Proc. Natl. Acad. Sci. U.S.A. 94 1 (1997) 163-168
10. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl. Acids Res. 11 (1983) 1475-1489
11. Furth P.A., and Baker C.C. An element in the bovine papillomavirus late 3′ untranslated region reduces polyadenylated cytoplasmic RNA levels. J. Virol. 65 11 (1991) 5806-5812
12. Furth P.A., Choe W.T., Rex J.H., Byrne J.C., and Baker C.C. Sequences homologous to 5′ splice sites are required for the inhibitory activity of papillomavirus late 3′ untranslated regions. Mol. Cell. Biol. 14 8 (1994) 5278-5289
13. Hebner C.M., and Laimins L. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol. 16 (2006) 83-97
14. Howley P.M., and Lowy D.R. Papillomaviridae and their replication. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Virology vol. 2 (2001), Lippincott/The Williams & Wilkins Co., Philadelphia, PA 2197-2229
15. Kennedy I.M., Haddow J.K., and Clements J.B. Analysis of human papillomavirus type 16 late mRNA 3′ processing signals in vitro and in vivo. J. Virol. 64 4 (1990) 1825-1829
16. Kennedy I.M., Haddow J.K., and Clements J.B. A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J. Virol. 65 4 (1991) 2093-2097
17. Koffa M.D., Graham S.V., Takagaki Y., Manley J.L., and Clements J.B. The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels. Proc. Natl. Acad. Sci. U.S.A. 97 9 (2000) 4677-4682
18. McPhillips M.G., Veerapraditsin T., Cumming S.A., Karali D., Milligan S.G., Boner W., Morgan I.M., and Graham S.V. SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells. J. Virol. 78 19 (2004) 10598-10605
19. Oberg D., Collier B., Zhao X., and Schwartz S. Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells. J. Virol. 77 (2003) 11674-11684
20. Schwartz S., Zhao X., Öberg D., and Rush M. Regulation of papillomavirus late gene expression. Recent Res. Develop. Virol. 6 (2004) 29-45
21. Sokolowski M., Furneaux H., and Schwartz S. The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3′ untranslated region correlates with its affinity for the elav-like HuR protein. J. Virol. 73 2 (1999) 1080-1091
22. Sokolowski M., and Schwartz S. Heterogeneous nuclear ribonucleoprotein C binds exclusively to the functionally important UUUUU-motifs in the human papillomavirus type-1 AU-rich inhibitory element. Virus Res. 73 2 (2001) 163-175
23. Sokolowski M., Tan W., Jellne M., and Schwartz S. mRNA instability elements in the human papillomavirus type 16 L2 coding region. J. Virol. 72 2 (1998) 1504-1515
24. Sokolowski M., Zhao C., Tan W., and Schwartz S. AU-rich mRNA instability elements on human papillomavirus type 1 late mRNAs and c-fos mRNAs interact with the same cellular factors. Oncogene 15 19 (1997) 2303-2319
25. Tan W., Felber B.K., Zolotukhin A.S., Pavlakis G.N., and Schwartz S. Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. J. Virol. 69 9 (1995) 5607-5620
26. Tan W., and Schwartz S. The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3′ untranslated region. J. Virol. 69 5 (1995) 2932-2945
27. Wiklund L., Sokolowski M., Carlsson A., Rush M., and Schwartz S. Inhibtion of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 3′ untranslated region. J. Biol. Chem. 277 (2002) 40462-40471
28. Zhao C., Tan W., Sokolowski M., and Schwartz S. Identification of nuclear and cytoplasmic factors that interact specifically with an AU-rich, cis-acting inhibitory sequence in the 3′ untranslated region of human papillomavirus type 1 late mRNAs. J. Virol. 70 (1996) 3659-3667
29. Zhao X., Rush M., and Schwartz S. Identification of an hnRNP A1 dependent splicing silencer in the HPV-16 L1 coding region that prevents premature expression of the late L1 gene. J. Virol. 78 (2004) 10888-10905
30. Zheng Z.M., and Baker C.C. Papillomavirus genome structure, expression, and posttranscriptional regulation. Front. Biosci. 11 (2006) 2286-2302
31. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim. Biophys. Acta 1288 2 (1996) F55-F78
32. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 5 (2002) 342-350